ADR120S, Inc. (TYO:3750)
Japan · Delayed Price · Currency is JPY 869.00
+1.00 (0.12%)
At close: Feb 6, 2026
ADR120S Revenue
ADR120S had revenue of 12.00M JPY in the quarter ending September 30, 2025, a decrease of -76.92%. This brings the company's revenue in the last twelve months to 49.00M, down -93.79% year-over-year. In the fiscal year ending March 31, 2025, ADR120S had annual revenue of 122.00M, down -92.18%.
Revenue (ttm)
49.00M
Revenue Growth
-93.79%
P/S Ratio
158.34
Revenue / Employee
4.90M
Employees
10
Market Cap
7.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 122.00M | -1.44B | -92.18% |
| Mar 31, 2024 | 1.56B | -584.00M | -27.24% |
| Mar 31, 2023 | 2.14B | 809.00M | 60.60% |
| Mar 31, 2022 | 1.34B | -53.00M | -3.82% |
| Mar 31, 2021 | 1.39B | 208.00M | 17.63% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Linical | 9.87B |
| Soiken Holdings | 4.87B |
| CellSource | 3.71B |
| StemCell Institute | 2.72B |
| MEDINET | 998.00M |
| OncoTherapy Science | 956.00M |
| Chiome Bioscience | 727.99M |
| PRISM BioLab Co.,LTD | 677.33M |